Abbott's Q1 Earnings to Rise 10% on $12.91B Revenue

Abbott (ABT) rose 1.12% to $103.09, outperforming the S&P 500's 0.48% decline. The stock fell 8.36% in the past month, lagging the Medical sector's 2.01% loss. Abbott is expected to report Q4 EPS of $1.43, up 10% YoY, and revenue of $12.91 billion, up 13.52% YoY. The Zacks Consensus Estimates anticipate FY22 EPS of $5.52, up 7.18% YoY, and revenue of $50.32 billion, up 13.51% YoY. The stock currently has a Zacks Rank of #3 (Hold) and a Forward P/E ratio of 18.46, marking a discount compared to its peers.